Related Experiment Video
Updated: Aug 1, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes
Riccardo M Inciardi1, Robert P Giugliano2, Jeong-Gun Park2
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health; ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
Insights
Patients with atrial fibrillation (AF) and heart failure (HF) face higher risks of HF events than stroke or bleeding. Heart failure with reduced ejection fraction (HFrEF) carries a greater HF event risk than heart failure with preserved ejection fraction (HFpEF).
Area of Science:
- Cardiology
- Clinical Research
- Atrial Fibrillation Management
Background:
- The comparative risks of heart failure (HF) events versus stroke/systemic embolic events (SEE) or major bleeding (MB) in patients with atrial fibrillation (AF), stratified by HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), remain understudied.
- Understanding these risks is crucial for optimizing anticoagulation and HF management strategies in this complex patient population.
Purpose of the Study:
- To assess HF outcomes in AF patients based on HF history and HF phenotypes (HFrEF vs. HFpEF).
- To compare the incidence of HF hospitalizations (HHF) or HF death with the rates of fatal/nonfatal stroke/SEE and MB in AF patients.
- To evaluate subsequent mortality risk following HHF, stroke/SEE, or MB.
Main Methods:
- Analysis of patients from the ENGAGE-AF TIMI 48 trial.
- Assessment of cumulative incidence for HHF or HF death, compared with stroke/SEE and MB rates.
- Median follow-up duration of 2.8 years.
Main Results:
- Patients with a history of HF experienced higher rates of HHF or HF death (4.95 per 100 person-years) compared to stroke/SEE (1.77) and MB (2.66).
- HFrEF patients had a significantly higher rate of HHF or HF death than HFpEF patients (7.15 vs. 3.65).
- Rates of stroke/SEE and MB were similar between HFrEF and HFpEF phenotypes. Mortality following HHF was higher than following stroke/SEE or MB.
Conclusions:
- AF patients with HF, irrespective of ejection fraction, exhibit a heightened risk of HF events and subsequent mortality compared to stroke/SEE or MB.
- HFrEF is associated with a greater risk of HF events than HFpEF, although risks for stroke/SEE and MB are comparable between these HF phenotypes.
Background:
The risks of heart failure (HF) events compared with stroke/systemic embolic events (SEE) or major bleeding (MB) in heart failure with reduced ejection fraction (HFrEF) vs heart failure with preserved ejection fraction (HFpEF) in a large atrial fibrillation (AF) population have not been well-studied.
Objectives:
This study sought to assess HF outcomes, according to HF history and HF phenotypes (HFrEF vs HFpEF), and compare these events with SEE and MB, among patients with AF.
Methods:
We analyzed patients enrolled in the ENGAGE-AF TIMI 48 (Effective Anticoagulation with Factor Xa Next Generation in AF-Thrombolysis in Myocardial Infarction 48) trial. Cumulative incidence of heart failure hospitalization (HHF) or HF death was assessed and compared with the rates of fatal and nonfatal stroke/SEE and MB over a median follow-up of 2.8 years.
Results:
Overall, 12,124 (57.4%) had a history of HF (37.7% HFrEF, 40.1% HFpEF, 22.1% with unknown ejection fraction). The rate per 100 person-years (py) of HHF or HF death (4.95; 95% CI: 4.70-5.20) was higher than of fatal and nonfatal stroke/SEE (1.77; 95% CI: 1.63-1.92) and MB (2.66; 95% CI: 2.47-2.86) among patients with HF history. HFrEF patients experienced a higher rate of HHF or HF death compared with HFpEF patients (7.15 vs 3.65; P < 0.001), while the rates of fatal and nonfatal stroke/SEE and MB were similar by HF phenotype. Patients with HF history had a higher rate of mortality after a HHF (1.29; 95% CI: 1.17-1.42) than after a stroke/SEE (0.69; 95% CI: 0.60-0.78) or after MB (0.61; 95% CI: 0.53-0.70). Overall, patients with nonparoxysmal AF had a higher rate of HF and stroke/SEE events regardless of HF history.
Conclusions:
Patients with AF and HF, regardless of ejection fraction, are at a higher risk of HF events with higher subsequent mortality rates than of stroke/SEE or MB. While HFrEF is associated with a higher risk of HF events than HFpEF, the risk of stroke/SEE and MB is similar between HFrEF and HFpEF.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations

